BioCentury
ARTICLE | Finance

Picking through the remains

Althea picks up the last bits of bankrupt Altus Pharma, which had absorbed $300M

May 10, 2010 7:00 AM UTC

Althea Technologies Inc. acquired the remains of its now defunct manufacturing client Altus Pharmaceuticals Inc. for an undisclosed amount last week, and hopes to create value with the formulation assets while off-loading the early product pipeline candidates that still remain.

Altus, a one-time subsidiary of Vertex Pharmaceuticals Inc. (NASDAQ:...